Cognition Therapeutics Inc
NASDAQ:CGTX

Watchlist Manager
Cognition Therapeutics Inc Logo
Cognition Therapeutics Inc
NASDAQ:CGTX
Watchlist
Price: 0.239 USD -3.86% Market Closed
Market Cap: 14.8m USD

Intrinsic Value

CGTX's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one CGTX stock under the Base Case scenario is 0.404 USD. Compared to the current market price of 0.239 USD, Cognition Therapeutics Inc is Undervalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CGTX Intrinsic Value
0.404 USD
Undervaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cognition Therapeutics Inc

Valuation History Unavailable

Historical valuation for CGTX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Cognition Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cognition Therapeutics Inc

Current Assets 22.9m
Cash & Short-Term Investments 16.4m
Receivables 4.8m
Other Current Assets 1.7m
Non-Current Assets 634k
PP&E 634k
Efficiency

Free Cash Flow Analysis
Cognition Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cognition Therapeutics Inc

Revenue
0 USD
Operating Expenses
-53.6m USD
Operating Income
-53.6m USD
Other Expenses
20.3m USD
Net Income
-33.3m USD
Fundamental Scores

CGTX Profitability Score
Profitability Due Diligence

Cognition Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

Cognition Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

CGTX Solvency Score
Solvency Due Diligence

Cognition Therapeutics Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
52/100
Solvency
Score

Cognition Therapeutics Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CGTX Price Targets Summary
Cognition Therapeutics Inc

There are no price targets for CGTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cognition Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CGTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CGTX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CGTX stock?

The intrinsic value of one CGTX stock under the Base Case scenario is 0.404 USD.

Is CGTX stock undervalued or overvalued?

Compared to the current market price of 0.239 USD, Cognition Therapeutics Inc is Undervalued by 41%.

Back to Top